These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11723014)

  • 1. Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial.
    Fu Y; Goodman S; Chang WC; Van De Werf F; Granger CB; Armstrong PW
    Circulation; 2001 Nov; 104(22):2653-9. PubMed ID: 11723014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction.
    Armstrong PW; Wagner G; Goodman SG; Van de Werf F; Granger C; Wallentin L; Fu Y;
    Eur Heart J; 2003 Aug; 24(16):1515-22. PubMed ID: 12919776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of ST segment shift early after resolution of ST elevation in patients with myocardial infarction treated with thrombolytic therapy: the GUSTO-I ST Segment Monitoring Substudy.
    Langer A; Krucoff MW; Klootwijk P; Simoons ML; Granger CB; Barr A; Califf RM; Armstrong PW
    J Am Coll Cardiol; 1998 Mar; 31(4):783-9. PubMed ID: 9525547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognostic value of ST-segment resolution in patients treated with fibrinolysis or primary percutaneous coronary intervention results from the DANAMI-2 (DANish trial in acute myocardial infarction-2).
    Sejersten M; Valeur N; Grande P; Nielsen TT; Clemmensen P;
    J Am Coll Cardiol; 2009 Nov; 54(19):1763-9. PubMed ID: 19874989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy.
    Taher T; Fu Y; Wagner GS; Goodman SG; Fresco C; Granger CB; Wallentin L; van de Werf F; Verheugt F; Armstrong PW
    J Am Coll Cardiol; 2004 Jul; 44(1):38-43. PubMed ID: 15234403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of ST-segment deviation in the single ECG lead of maximum deviation present 90 or 180 minutes after start of thrombolytic therapy best predicts outcome in acute myocardial infarction.
    Schröder K; Wegscheider K; Zeymer U; Neuhaus KL; Schröder R
    Z Kardiol; 2001 Aug; 90(8):557-67. PubMed ID: 11565211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) trial.
    Schröder R; Wegscheider K; Schröder K; Dissmann R; Meyer-Sabellek W
    J Am Coll Cardiol; 1995 Dec; 26(7):1657-64. PubMed ID: 7594100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ST resolution in a single electrocardiographic lead: a simple and accurate predictor of cardiac mortality in patients with fibrinolytic therapy for acute ST-elevation myocardial infarction.
    Zeymer U; Schröder K; Wegscheider K; Senges J; Neuhaus KL; Schröder R
    Am Heart J; 2005 Jan; 149(1):91-7. PubMed ID: 15660039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy).
    Cura FA; Roffi M; Pasca N; Wolski KE; Lincoff AM; Topol EJ; Lauer MS;
    Am J Cardiol; 2004 Oct; 94(7):859-63. PubMed ID: 15464665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.
    Anderson RD; White HD; Ohman EM; Wagner GS; Krucoff MW; Armstrong PW; Weaver WD; Gibler WB; Stebbins AL; Califf RM; Topol EJ
    Am Heart J; 2002 Jul; 144(1):81-8. PubMed ID: 12094192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ST-segment recovery and prognosis in patients with ST-elevation myocardial infarction reperfused by prehospital combination fibrinolysis, prehospital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention.
    Thiele H; Scholz M; Engelmann L; Storch WH; Hartmann A; Dimmel G; Pfeiffer D; Schuler G;
    Am J Cardiol; 2006 Nov; 98(9):1132-9. PubMed ID: 17056313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. System delay and timing of intervention in acute myocardial infarction (from the Danish Acute Myocardial Infarction-2 [DANAMI-2] trial).
    Nielsen PH; Terkelsen CJ; Nielsen TT; Thuesen L; Krusell LR; Thayssen P; Kelbaek H; Abildgaard U; Villadsen AB; Andersen HR; Maeng M;
    Am J Cardiol; 2011 Sep; 108(6):776-81. PubMed ID: 21757183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of two unfractionated heparin dosing strategies with tenecteplase in acute myocardial infarction (results from Assessment of the Safety and Efficacy of a New Thrombolytic Regimens 2 and 3).
    Curtis JP; Alexander JH; Huang Y; Wallentin L; Verheugt FW; Armstrong PW; Krumholz HM; Van de Werf F; Danays T; Cheeks M; Granger CB;
    Am J Cardiol; 2004 Aug; 94(3):279-83. PubMed ID: 15276088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.
    Wallentin L; Goldstein P; Armstrong PW; Granger CB; Adgey AA; Arntz HR; Bogaerts K; Danays T; Lindahl B; Mäkijärvi M; Verheugt F; Van de Werf F
    Circulation; 2003 Jul; 108(2):135-42. PubMed ID: 12847070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3.
    Johanson P; Fu Y; Wagner GS; Goodman SG; Granger CB; Wallentin L; Van de Werf F; Armstrong PW;
    Am J Cardiol; 2009 Jan; 103(2):154-8. PubMed ID: 19121428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.
    Sinnaeve PR; Armstrong PW; Gershlick AH; Goldstein P; Wilcox R; Lambert Y; Danays T; Soulat L; Halvorsen S; Ortiz FR; Vandenberghe K; Regelin A; Bluhmki E; Bogaerts K; Van de Werf F;
    Circulation; 2014 Sep; 130(14):1139-45. PubMed ID: 25161043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).
    Tan NS; Goodman SG; Cantor WJ; Tan MK; Yan RT; Bagnall AJ; Mehta SR; Fitchett D; Strauss BH; Yan AT;
    Am J Cardiol; 2014 Oct; 114(7):955-61. PubMed ID: 25118119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
    Jarai R; Huber K; Bogaerts K; Droogne W; Ezekowitz J; Granger CB; Sinnaeve PR; Ross AM; Zeymer U; Armstrong PW; Van de Werf FJ;
    Am Heart J; 2010 Jan; 159(1):131-40. PubMed ID: 20102879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.